-+ 0.00%
-+ 0.00%
-+ 0.00%

Raymond James Upgrades InflaRx to Strong Buy, Raises Price Target to $9

Benzinga·05/13/2026 17:53:22
Listen to the news
Raymond James analyst Ryan Deschner upgrades InflaRx (NASDAQ:IFRX) from Outperform to Strong Buy and raises the price target from $7 to $9.